Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study

Fertility and Sterility

Volumn 100, Issue 2, 2013, Pages 438-444

  Polyzos, Nikolaos P ^a   Nelson, Scott M ^b   Stoop, Dominic ^a   Nwoye, Milie ^a   Humaidan, Peter ^c   Anckaert, Ellen ^a   Devroey, Paul ^a   Tournaye, Herman ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

AMH; AMH variability; excessive responders; OHSS; ovarian response; poor responder; stimulation; time interval

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN ANTAGONIST; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; COHORT ANALYSIS; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HORMONAL THERAPY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; LUTEAL PHASE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARIAN RESERVE; OVARIAN STIMULATION; OVULATION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TIME TO TREATMENT; TRANSVAGINAL ECHOGRAPHY;

AMH; AMH VARIABILITY; EXCESSIVE RESPONDERS; OHSS; OVARIAN RESPONSE; POOR RESPONDER; STIMULATION; TIME INTERVAL;

ADULT; ANTI-MULLERIAN HORMONE; BLOOD SPECIMEN COLLECTION; COHORT STUDIES; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; MALE; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME FACTORS;

EID: 84881177823     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.03.031     Document Type: Article

References (30)

1. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, and A.C. Artenisio Anti-müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum Reprod Update 16 2010 113 130
2. S.L. Broer, B.W. Mol, D. Hendriks, and F.J. Broekmans The role of antimüllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil Steril 91 2009 705 714
3. S.L. Broer, M. Dolleman, B.C. Opmeer, B.C. Fauser, B.W. Mol, and F.J. Broekmans AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis Hum Reprod Update 17 2011 46 54
4. S.M. Nelson, R.W. Yates, and R. Fleming Serum anti-müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles - implications for individualization of therapy Hum Reprod 22 2007 2414 2421
5. T.C. van Tilborg, M.J. Eijkemans, J.S. Laven, C.A. Koks, J.P. de Bruin, and G.J. Scheffer The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial BMC Womens Health 12 2012 29
6. S.M. Nelson, R.W. Yates, H. Lyall, M. Jamieson, I. Traynor, and M. Gaudoin Anti-müllerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum Reprod 24 2009 867 875
7. A.P. Yates, S.A. Roberts, and L.G. Nardo Anti-müllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF Hum Reprod 27 2012 629
8. Confidential Enquiry into Maternal and Child Health Saving mothers' lives: reviewing maternal deaths to make motherhood safer 2003-2005. 7th report 2007 CEMACH London
9. D.D. Braat, J.M. Schutte, R.E. Bernardus, T.M. Mooij, and F.E. van Leeuwen Maternal death related to IVF in the Netherlands 1984-2008 Hum Reprod 25 2010 1782 1786
10. P. Devroey, N.P. Polyzos, and C. Blockeel An OHSS-Free Clinic by segmentation of IVF treatment Hum Reprod 26 2011 2593 2597
11. A.P. Yates, O. Rustamov, S.A. Roberts, H.Y. Lim, P.W. Pemberton, and A. Smith Anti-müllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF Hum Reprod 26 2011 2353 2362
12. C. Gnoth, A.N. Schuring, K. Friol, J. Tigges, P. Mallmann, and E. Godehardt Relevance of anti-müllerian hormone measurement in a routine IVF program Hum Reprod 23 2008 1359 1365
13. I.A. van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, and F.H. de Jong Serum anti-müllerian hormone levels: a novel measure of ovarian reserve Hum Reprod 17 2002 3065 3071
14. B. Almog, F. Shehata, S. Suissa, H. Holzer, E. Shalom-Paz, and A. La Marca Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study Fertil Steril 95 2011 2359 2363 2363.e1
15. S.M. Nelson, M.C. Messow, A.M. Wallace, R. Fleming, and A. McConnachie Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients Fertil Steril 95 2011 736 741.e1-3
16. A.G. Mulders, J.S. Laven, M.J. Eijkemans, F.H. de Jong, A.P. Themmen, and B.C. Fauser Changes in anti-müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility Hum Reprod 19 2004 2036 2042
17. N.P. Polyzos, and P. Devroey A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril 96 2011 1058 1061.e7
18. A.P. Ferraretti, A. La Marca, B.C. Fauser, B. Tarlatzis, G. Nargund, and L. Gianaroli ESHRE consensus on the definition of "poor response" to ovarian stimulation for in vitro fertilization: the Bologna criteria Hum Reprod 26 2011 1616 1624
19. N.P. Polyzos, H. Tournaye, and P. Devroey AMH for predicting poor ovarian responders in GnRH antagonist cycles Hum Reprod 27 2012 1876 1877
20. H. Janes, G. Longton, and M.S. Pepe Accommodating covariates in receiver operating characteristic analysis Stata J 9 2009 17 39
21. H. Janes, and M.S. Pepe Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve Biometrika 96 2009 371 382
22. M.P. Rosen, E. Johnstone, C.E. McCulloch, S.M. Schuh-Huerta, B. Sternfeld, and R.A. Reijo-Pera A characterization of the relationship of ovarian reserve markers with age Fertil Steril 97 2012 238 243
23. T.W. Kelsey, P. Wright, S.M. Nelson, R.A. Anderson, and W.H. Wallace A validated model of serum anti-müllerian hormone from conception to menopause PLoS One 6 2011 e22024
24. J. van Disseldorp, C.B. Lambalk, J. Kwee, C.W. Looman, M.J. Eijkemans, and B.C. Fauser Comparison of inter- and intra-cycle variability of anti-müllerian hormone and antral follicle counts Hum Reprod 25 2010 221 227
25. W.J. Hehenkamp, C.W. Looman, A.P. Themmen, F.H. de Jong, E.R. Te Velde, and F.J. Broekmans Anti-müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation J Clin Endocrinol Metab 91 2006 4057 4063
26. R. Fanchin, J. Taieb, D.H. Lozano, B. Ducot, R. Frydman, and J. Bouyer High reproducibility of serum anti-müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status Hum Reprod 20 2005 923 927
27. A. Overbeek, F.J. Broekmans, W.J. Hehenkamp, M.E. Wijdeveld, J. van Disseldorp, and E. van Dulmen-den Broeder Intra-cycle fluctuations of anti-müllerian hormone in normal women with a regular cycle: a re-analysis Reprod Biomed Online 24 2012 664 669
28. M. Sowers, D. McConnell, K. Gast, H. Zheng, B. Nan, and J.D. McCarthy Anti-müllerian hormone and inhibin B variability during normal menstrual cycles Fertil Steril 94 2010 1482 1486
29. W.H. Wallace, and T.W. Kelsey Human ovarian reserve from conception to the menopause PLoS One 5 2010 e8772
30. S.M. Nelson, and D.A. Lawlor Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles PLoS Med 8 2011 e1000386